Rituximab decreases without preference all subclasses of IgG anti-BP180 autoantibodies in refractory bullous pemphigoid (BP).

Published

Journal Article (Letter)

Full Text

Duke Authors

Hall III, Russell P.

Cited Authors

Ronaghy, A; Streilein, RD; Hall, RP

Published Date

April 2014

Published In

Journal of Dermatological Science

Volume / Issue

74 / 1

Start / End Page

93 - 94

PubMed ID

24461673

Pubmed Central ID

24461673

Electronic International Standard Serial Number (EISSN)

1873-569X

International Standard Serial Number (ISSN)

0923-1811

Digital Object Identifier (DOI)

10.1016/j.jdermsci.2013.11.014

Language

eng